Somatomedin-1 (Recombinant Insulin-Like Growth Factor-1): Clinical Pharmacology and Potential Treatment of Endocrine and Metabolic Disorders

Author： Laron Z.

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.11, Iss.1, 1999-01, pp. : 55-70

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Somatomedin-1 binding protein-3: Insulin-like growth factor-1 binding protein-3, Insulin-like growth factor-1 carrier protein

By Limited A.I.

BioDrugs, Vol. 17, Iss. 5, 2003-01 ,pp. : 375-379

Adis International

Access to resources Recommend Favorite

Insulin-Like Growth Factor-I Deficiency in Children with Growth Hormone Insensitivity: Current and Future Treatment Options

By Kemp Stephen F.

BioDrugs, Vol. 23, Iss. 3, 2009-06 ,pp. : 155-163

Adis International

Access to resources Recommend Favorite

Recombinant Hirudin: Clinical Pharmacology and Potential Applications in Nephrology

By vanholder R. Dhondt A.

BioDrugs, Vol. 11, Iss. 6, 1999-06 ,pp. : 417-429

Adis International

Access to resources Recommend Favorite

Recombinant Human Thyroid-Stimulating Hormone: Pharmacology, Clinical Applications and Potential Uses

By Emerson C.H. Torres M.S.T.

BioDrugs, Vol. 17, Iss. 1, 2003-01 ,pp. : 19-38

Adis International

Access to resources Recommend Favorite

Recombinant Relaxin: A Review of Pharmacology and Potential Therapeutic Use

By Gavino E.S. Furst D.E.

BioDrugs, Vol. 15, Iss. 9, 2001-09 ,pp. : 609-614

Adis International

Access to resources Recommend Favorite